Interestingly, increasing evidence supports the notion that human GAPDH interacts with neurodegenerative disease‐related proteins, like α‐synuclein, by promoting the accumulation of oligomers and toxic aggregates (Ávila et al., 2014; Mikhaylova et al., 2016). This evidence concerns the gene GAPDH and neurodegenerative disease.